Credit Suisse analyst Erin Wright maintained a Hold rating on Charles River Labs (CRL) yesterday and set a price target of $134. The company’s shares closed yesterday at $136.23, close to its 52-week high of $138.89.
According to TipRanks.com, Wright is ranked #645 out of 4907 analysts.
Currently, the analyst consensus on Charles River Labs is a Moderate Buy with an average price target of $133.50.
See today’s analyst top recommended stocks >>
Charles River Labs’ market cap is currently $6.01B and has a P/E ratio of 51.80. The company has a Price to Book ratio of 5.53.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions.
